Latest Breaking News On - Verastem oncology - Page 1 : vimarsana.com

Verastem Oncology Announces Positive Initial Interim Safety and Efficacy Results from RAMP 205 Trial Evaluating Avutometinib Plus Defactinib in Combination with Gemcitabine and Nab-paclitaxel in First-Line Metastatic Pancreatic Cancer

Verastem Oncology announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 clinical trial evaluating avutometinib plus defactinib in combination with gemcitabine.

United statesEastern cooperative oncology groupAmerican society of clinical oncologyVerastem oncologyAmerican societyClinical oncologyAnnual meetingPerformance status

Verastem Oncology Announces the Initiation of a Rolling Submission of NDA to FDA Seeking Accelerated Approval of Avutometinib and Defactinib Combination for the Treatment of Adult Patients with Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer

Verastem Oncology Announces the Initiation of a Rolling Submission of NDA to FDA Seeking Accelerated Approval of Avutometinib and Defactinib Combination for the Treatment of Adult Patients with Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

South koreaUnited kingdomDan patersonEuropean network of gynaecological oncological trialChugai pharmaceutical co ltdCompany annual report on formExchange commissionRaf and mek programGenfleet therapeutics shanghai incSecura bio incDrug administrationFoundation incVerastem oncologyNew drug applicationBreakthrough therapy designationOrphan drug designation

What s Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?

What s Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

United statesAmerican societyVerastem oncology

ASCO 2024: Verastem s combo therapy for pancreatic cancer hits early trial success

ASCO 2024: Verastem s combo therapy for pancreatic cancer hits early trial success
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

United statesAmerican society of clinical oncologyVerastem oncologyAmerican societyClinical oncologyAnnual meeting

Brown Highlights the Rationale for the RAMP-301 Trial in Low-Grade Serous Ovarian Cancer

Brown Highlights the Rationale for the RAMP-301 Trial in Low-Grade Serous Ovarian Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

North carolinaUnited statesAshling wahnerLive on airVerastem oncologyJubilee brownGynecologic oncologyAtrium health levine cancer instituteOnclive on airApple podcastsGoogle podcastsAmazon music